INmune Bio Inc. (INMB)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$2.01+$0.0100 (+0.50%) on the dayAs of the close; data may be delayed.
INMB price, last 12 months
Key stats
- Previous close
- $2.00
- Open
- $1.95
- Day range
- $1.95 – $2.05
- 52-week range
- $1.09 – $2.60
- Volume
- 182.2K
- Avg volume (20 days)
- 348.6K
- Market cap
- $56.3M
Performance
1W−13.7%
1M−17.8%
3M+41.6%
6M+67.5%
YTD+28.9%
1Y+3.1%
vs S&P 500, 1Y−13.7 pts
Technicals and fundamentals
About INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $56.3M